# The efficacy and safety of low-dose roxadustat in combination with recombinant human erythropoietin for treating hemodialysis patients with moderate anemia: A retrospective cohort study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-efficacy-and-safety-of-low-dose-roxadustat-in-combination-with-recombinant/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yanfei Huang,Xinxin Jiang,Guiqin Shu,Hui Li,Jingjing Lin,Qing‐Qing Duan,Xue Cao,Min Cheng,Zhigui Zheng |
| Citations | 2 |
| DOI | 10.5414/cn111433 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4405082001 |
| PMID | 39635729 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Zhigui Zheng](https://scholariq.org/researchers/zhigui-zheng/)

## Paper journal

- [Clinical Nephrology](https://scholariq.org/journals/clinical-nephrology/)

## Paper primary topic

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Paper topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.